Making The Case For Responsible Science For A Safe Environment 19/11/2010 by Intellectual Property Watch Leave a Comment Innovation or “jugaad” has always driven the Indian economy. However, the last decade has been witness to an emerging paradigm shift to high-quality value-added innovation, writes industry lawyer Sunita K. Sreedharan.
WIPO Copyright Committee Agrees To Extra Time On Visually Impaired Access 15/11/2010 by Kaitlin Mara for Intellectual Property Watch 4 Comments The World Intellectual Property Organization copyright committee has reached an eleventh-hour agreement on a work programme that could help ease access to reading materials for the visually impaired.
WIPO Copyright Committee In Fight To Overcome Differences On Exceptions, Limitations 12/11/2010 by Kaitlin Mara for Intellectual Property Watch 3 Comments On the World Intellectual Property Organization committee on copyright’s final day of weeklong negotiations, the hopes of visually impaired readers and others – librarians, schools – looking for an agreement on copyright exceptions and limitations hang on whether delegates can resolve differences and create a plan for future work.
Global Copyright Reform — A View From The South In Response To Lessig 12/11/2010 by Intellectual Property Watch 7 Comments “Given that global copyright rules have acquired such a pervasive impact in many facets of our lives, their reform needs to take place through an open, inclusive and participatory consultation process where ‘all of us’ have a say,” writes Ahmed Abdel Latif.
حكاية لقارئ من ضعاف البصر 11/11/2010 by Inside Views, Intellectual Property Watch Leave a Comment بكل احترام يسعدني أن أضع تجربتي الشخصية , بين يدي كل من يهمه أن يطلع عليه متمنين أن تكون إفهاما متواضعا لأجل الوصول إلى اتفاقية دولية تيسر الاطلاع على المعرفة لذوي الاحتياجات الخاصة. د/ محمد محسن النجار يكتب تجربته
A Tale Of A Visually Impaired Reader 11/11/2010 by Intellectual Property Watch 1 Comment I’d like to introduce myself and put my personal experience in the hands of all concerned parties and people, hoping that this will help to give a better comprehension (explain) about the situation of blind people and to help reach an international treaty that will facilitate access to knowledge for people with visual impairments, writes law professor Mohammed Mohsin Abrahim El Nagaar of Alexandria University.
Panellists: Copyright Law’s ‘Byzantine Maze’ Stalling New Business Models 09/11/2010 by Kaitlin Mara for Intellectual Property Watch 2 Comments While piracy remains an oft-cited problem for the creative content industry, it is the ‘Byzantine maze’ of copyright law that is stalling monetisation of new business models better designed to deliver content in the digital age, panellists at the World Intellectual Property Organization said last week.
European Officials Eye Pan-European Passport For Collective Copyright Licencing 08/11/2010 by William New, Intellectual Property Watch Leave a Comment The European Commission is considering a proposal in the coming months to create a pan-European passport for collective music licensing intended to overcome stifling difficulties of 27 national collecting societies, a top official has told Intellectual Property Watch in the context of a meeting on copyright and competition.
WIPO Copyright Committee Tackles Visually Impaired Access, Other Exceptions 08/11/2010 by William New, Intellectual Property Watch 4 Comments The World Intellectual Property Organization Standing Committee on Copyright and Related Rights (SCCR) is meeting this week in an attempt to advance proposals to improve global access to copyrighted works, following a disappointing summer meeting that ended without agreement. This week’s meeting also includes renewed discussions of proposed treaties on broadcasters’ rights and rights over audiovisual performances.
US FDA’s Tough Road Ahead In Creating Pathway For Life-Saving Biologics 07/11/2010 by Liza Porteus Viana, Intellectual Property Watch Leave a Comment The US Food and Drug Administration heard from myriad pharmaceutical companies, patient groups, and other stakeholders last week as the agency considers how to create an abbreviated pathway to bring more biologic drugs to market.